SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-086579
Filing Date
2008-04-22
Accepted
2008-04-22 12:50:10
Documents
3
Period of Report
2008-06-05
Effectiveness Date
2008-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 306141
3 GRAPHIC g47495img001.jpg GRAPHIC 3046
4 GRAPHIC g47495img002.jpg GRAPHIC 5160
  Complete submission text file 0001193125-08-086579.txt   319289
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15360 | Film No.: 08768745
SIC: 3841 Surgical & Medical Instruments & Apparatus